“Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center”. 2026. Mediterranean Journal of Hematology and Infectious Diseases 18 (1). https://doi.org/10.4084/MJHID.2026.044.